Dipyridamole inhibits adenosine uptake by platelets and endothelial cells, which is a circadian adenosine monophosphate accession triggers (cAMP) and inhibition of the dispatch of platelet aggregation. By agents such as platelet activating agency and collagen Dipyridamole aswell has non-medical applications in a lab environment, such as advance inhibition cardio in corpuscle culture.
Dipyridamole inhibits phosphodiesterase enzymes that commonly breach down cAMP and / or cGMP.Dipyridamole is acclimated to anticipate claret clots afterwards affection valve backup surgery.Dipyridamole can aswell be acclimated for added purposes not listed in this medication guide.Dipyridamole is a constructed abettor acquired of pyrimido-pyrimidine, with antiplatelet properties.
No comments:
Post a Comment